Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions and methods for the storage of red blood cells

a technology of red blood cell and composition, applied in the field of compositions and methods for improving the storage of red blood cells, can solve the problems of scientifically tricky preservation, incremental steps to achieve longer storage duration and higher quality re-infused red blood cells, and reduce the percent recovery of the resulting “packed rbc"

Inactive Publication Date: 2012-05-24
UNIVERSITY OF CINCINNATI +1
View PDF1 Cites 29 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides novel compositions for storing and preserving red blood cells. By eliminating sodium chloride from the compositions, the inventors discovered that the compositions have an increased capacity for a pH buffering system, which improves the integrity and physiological functioning quality of the stored red blood cells. The compositions retain their superior performance at conventional volumes, making them particularly suitable for storing red blood cells which may be targeted for infusion into multiply or massively transfused patients. The inventive compositions are also operable to maintain the pH of the red blood cell during storage, which helps to maintain the quality of the stored cells for a longer period of time. The inventive compositions and methods of using them provide a storage period for red blood cells throughout which a sufficient therapeutic amount of the cells is recoverable and are directly infusible into patients without further processing.

Problems solved by technology

Such preservation is scientifically tricky and the steps to achieving longer storage duration and higher quality re-infused red blood cells have been incremental.
This, however, led to a reduction in the percent recovery of the resulting “packed RBC.”
Red blood cells (RBCs) stored in these solutions, however, undergo steady deterioration after about 6 weeks as determined by the inability of 75% of such cells to survive in the circulation for 24 hours after re-infusion back into the human donor.
Each of the U.S.-licensed ASs meet the licensure requirements for 6-week RBC storage, but fail to achieve 7-week storage.
However, packed RBCs stored in EAS-2 were not directly infusible but required the removal of the supernatant with a washing step prior to transfusion due to the presence of ammonium in the additive solution.
However, the resulting RBC units contained about 1 percent glycerol and thus, are not safe for transfusion in humans in large amounts.
However, such stored RBC suspensions were not acceptable for direct infusion due to their high content of potassium and ammonia and their low volume fraction of RBCs.
Although these EASs yielded superior performance results, they contained sodium chloride and were formulated to require a relatively large volume resulting in greater dilution of the stored RBC, thus increasing the risk of hemodilution in multiply transfused patient recipients.
In addition, the presence of sodium chloride created a solubility limit on the amount of buffering salts and phosphates that the system could sustain at desirable volumes.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for the storage of red blood cells
  • Compositions and methods for the storage of red blood cells

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0063]This example illustrates a performance profile and the advantages of one embodiment of the inventive additive solution composition, designated as EAS-81 (see Table 1). EAS-81 and comparative example AS-3 (Nutricel, Pal Biomedical) are both provided in conventional volumes, while comparative examples EAS-61 and EAS-76v6 are provided in more dilute, larger volumes. EAS-81 and EAS-76v6 both comprise bicarbonate. See FIG. 1, wherein the bicarbonate-containing compositions are represented by circles, while those without bicarbonate are represented by diamonds. Higher volume compositions are represented by solid figures while the conventional volume compositions are represented by open figures. All volumes of additive solution compositions disclosed herein are understood to be per 500 mL unit of whole blood for an approximate volumetric ratio of 1:4.5.

[0064]The first example is conducted as a pooling study in order to evaluate the effect of storage solution ingredients on RBC metabo...

example 2

[0073]This example illustrates that an inventive EAS formulation permitted the storage of RBC in conventional-volume additive solution for 8 weeks, with better recovery, lower hemolysis and enhanced membrane preservation over the known 6-week storage solution.

[0074]Twelve volunteer subjects meeting the United States Food and Drug Administration (FDA) and American Association of Blood Banks donor criteria were selected. The subjects donated 500 mL (one unit) of whole blood, which was collected in CP2D primary bag (Item code #127-23, Pall Corporation, East Hills, N.Y.), and leuko-reduced with all but about 65 mL of the plasma removed. EAS-81, 110 mL, was added and the packed RBC solutions were stored upright at 1-6° C. with half the samples (n=6) being stored for 6 weeks and half (n=6) for 8 weeks. The week prior to the end of storage, the units were sterilely sampled and cultured. If the culture exhibited no growth, a small aliquot of the stored RBC was labeled with 51-Cr and returne...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides an aqueous composition for storage of red blood cells consisting essentially of: adenine; dextrose; at least one nonmetabolizable membrane-protectant sugar; and a specifically defined pH buffering system. Also provided are improved methods for preserving red blood cells and methods for increasing the viability, membrane retention, and recoverability while suppressing apoptosis, hemolysis, and post-reinfusion clearance of stored red blood cells which utilize the novel compositions.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a divisional of and, pursuant to 35 U.S.C. §120, claims the benefit of U.S. patent application Ser. No. 11 / 060,026, filed on Feb. 17, 2005, which is pending as of the filing date of this application. Application Ser. No. 11 / 060,026, pursuant to 35 U.S.C. §119(e)(1), claimed priority from Provisional Application Ser. No. 60 / 545,582, filed on Feb. 18, 2004 under 35 U.S.C. §111(b). Both application Ser. No. 11 / 060,026 and Provisional Application Ser. No. 60 / 545,582 are hereby incorporated by reference in their entireties.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT[0002]Portions of this work were performed under U.S. Army contract DAMD 17-95-C-5029 and the U.S. government may have an ownership interest herein.BACKGROUND OF THE INVENTION[0003]The invention generally relates to compositions and methods associated with the storage of red blood cells (RBCs). In particular, it relates to an improved RBC stor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A01N1/02
CPCA01N1/02C12N5/0641A01N1/0221A01N1/021A01N1/0226
Inventor HESS, JOHN R.GREENWALT, TIBOR J.
Owner UNIVERSITY OF CINCINNATI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products